株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

神経インターベンション装置:医療機器のパイプライン評価

Interventional Neurology - Medical Devices Pipeline Assessment, 2017

発行 GlobalData 商品コード 350913
出版日 ページ情報 英文 291 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.89円で換算しております。
Back to Top
神経インターベンション装置:医療機器のパイプライン評価 Interventional Neurology - Medical Devices Pipeline Assessment, 2017
出版日: 2017年06月01日 ページ情報: 英文 291 Pages
概要

当レポートでは、世界のインターベンショナル神経学装置 (介入性神経学装置、神経インターベンション) の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • インターベンショナル神経学装置市場の概要

第3章 インターベンショナル神経学装置市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • インターベンショナル神経学装置の企業:治験段階別のパイプライン製品
  • インターベンショナル神経学装置:治験段階別のパイプライン製品

第5章 インターベンショナル神経学装置市場:企業・製品の概要

  • Alcyone Lifesciences Inc
  • Amnis Therapeutics Ltd
  • Anaconda BioMed SL
  • Aneuclose LLC
  • Apeliotus Technologies
  • Arterain Medical Inc (Inactive)
  • Avantec Vascular Corporation
  • BioCure, Inc.
  • Ceretrieve Ltd
  • Codman & Shurtleff Inc
  • Collagen Matrix Inc
  • Cordis Corp
  • CranioVation
  • CVTec Cerebrovascular Technologies GmbH
  • Dartmouth College
  • DePuy Synthes Inc
  • EchoGuide Medical, Inc. (Inactive)
  • Ecole Polytechnique Federale de Lausanne
  • Gaudi Vascular, Inc.
  • Hansen Medical Inc
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Hibernia Medical
  • Insera Therapeutics, LLC
  • InspireMD Inc
  • Medikit Co Ltd
  • Medtronic plc
  • Merlin MD Pte. Ltd.
  • Metactive Medical LLC
  • MicroPort Scientific Corp
  • MicroVention, Inc.
  • MindFrame Inc
  • MiVi Neuroscience, LLC
  • MRI Interventions Inc
  • NEOS Surgery SL
  • Neuravi Ltd
  • NeuroInterventional Therapeutics, Inc.
  • NeuroInterventions
  • Neurosigma Inc
  • Neurosyntec LLC. (Inactive)
  • NexGen Medical Systems Inc
  • NSVascular, Inc.
  • Oxford Endovascular Limited
  • Palmaz Scientific Inc
  • Penumbra Inc
  • Philips Healthcare
  • PhotoThera Inc (Inactive)
  • Pulsar Vascular, Inc.
  • Pulse Therapeutics Inc
  • Rapid Medical
  • Rontis AG
  • Shape Memory Therapeutics, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Strategic Polymer Sciences, Inc
  • Taewoong Medical Co Ltd
  • テルモ
  • Triticum Medical Ltd.
  • Twin Star Medical Inc
  • University of California Los Angeles
  • University of California San Francisco
  • University of Minnesota
  • University of South Florida
  • University of Wisconsin Madison
  • University of Wolverhampton
  • Valor Medical Inc
  • Vascular Solutions Inc
  • Viket Medical Corporation
  • Weill Cornell Medical College
  • Zoll Medical Corporation

第6章 インターベンショナル神経学装置市場:昨今の動向

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's Medical Devices sector report, "Interventional Neurology - Medical Devices Pipeline Assessment, 2017" provides an overview of Interventional Neurology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Interventional Neurology under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Interventional Neurology under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Interventional Neurology Overview 15

3 Products under Development 16

  • 3.1 Interventional Neurology - Pipeline Products by Stage of Development 16
  • 3.2 Interventional Neurology - Pipeline Products by Segment 17
  • 3.3 Interventional Neurology - Pipeline Products by Territory 18
  • 3.4 Interventional Neurology - Pipeline Products by Regulatory Path 19
  • 3.5 Interventional Neurology - Pipeline Products by Estimated Approval Date 20
  • 3.6 Interventional Neurology - Ongoing Clinical Trials 21

4 Interventional Neurology - Pipeline Products under Development by Companies 22

  • 4.1 Interventional Neurology Companies - Pipeline Products by Stage of Development 22
  • 4.2 Interventional Neurology - Pipeline Products by Stage of Development 25

5 Interventional Neurology Companies and Product Overview 28

  • 5.1 Alcyone Lifesciences Inc Company Overview 28
  • 5.2 Amnis Therapeutics Ltd Company Overview 29
  • 5.3 Anaconda BioMed SL Company Overview 32
  • 5.4 Aneuclose LLC Company Overview 33
  • 5.5 Apeliotus Technologies Company Overview 35
  • 5.6 Arterain Medical Inc (Inactive) Company Overview 36
  • 5.7 Avantec Vascular Corporation Company Overview 37
  • 5.8 BioCure, Inc. Company Overview 39
  • 5.9 Ceretrieve Ltd Company Overview 40
  • 5.10 Codman & Shurtleff Inc Company Overview 41
  • 5.11 Collagen Matrix Inc Company Overview 44
  • 5.12 Cordis Corp Company Overview 45
  • 5.13 CranioVation Company Overview 46
  • 5.14 CVTec Cerebrovascular Technologies GmbH Company Overview 47
  • 5.15 Dartmouth College Company Overview 48
  • 5.16 DePuy Synthes Inc Company Overview 50
  • 5.17 EchoGuide Medical, Inc. (Inactive) Company Overview 52
  • 5.18 Ecole Polytechnique Federale de Lausanne Company Overview 53
  • 5.19 Gaudi Vascular, Inc. Company Overview 54
  • 5.20 Hansen Medical Inc Company Overview 55
  • 5.21 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 56
  • 5.22 Hibernia Medical Company Overview 57
  • 5.23 Insera Therapeutics, LLC Company Overview 58
  • 5.24 InspireMD Inc Company Overview 59
  • 5.25 Medikit Co Ltd Company Overview 60
  • 5.26 Medtronic plc Company Overview 64
  • 5.27 Merlin MD Pte. Ltd. Company Overview 71
  • 5.28 Metactive Medical LLC Company Overview 72
  • 5.29 MicroPort Scientific Corp Company Overview 73
  • 5.30 MicroVention, Inc. Company Overview 79
  • 5.31 MindFrame Inc Company Overview 88
  • 5.32 MiVi Neuroscience, LLC Company Overview 89
  • 5.33 MRI Interventions Inc Company Overview 90
  • 5.34 NEOS Surgery SL Company Overview 91
  • 5.35 Neuravi Ltd Company Overview 93
  • 5.36 NeuroInterventional Therapeutics, Inc. Company Overview 97
  • 5.37 NeuroInterventions Company Overview 98
  • 5.38 Neurosigma Inc Company Overview 99
  • 5.39 Neurosyntec LLC. (Inactive) Company Overview 100
  • 5.40 NexGen Medical Systems Inc Company Overview 101
  • 5.41 NSVascular, Inc. Company Overview 102
  • 5.42 Oxford Endovascular Limited Company Overview 103
  • 5.43 Palmaz Scientific Inc Company Overview 104
  • 5.44 Penumbra Inc Company Overview 105
  • 5.45 Philips Healthcare Company Overview 108
  • 5.46 PhotoThera Inc (Inactive) Company Overview 109
  • 5.47 Pulsar Vascular, Inc. Company Overview 114
  • 5.48 Pulse Therapeutics Inc Company Overview 115
  • 5.49 Rapid Medical Company Overview 118
  • 5.50 Rontis AG Company Overview 119
  • 5.51 Shape Memory Therapeutics, Inc. Company Overview 120
  • 5.52 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 122
  • 5.53 Strategic Polymer Sciences, Inc Company Overview 123
  • 5.54 Taewoong Medical Co Ltd Company Overview 124
  • 5.55 Terumo Corp Company Overview 125
  • 5.56 Triticum Medical Ltd. Company Overview 127
  • 5.57 Twin Star Medical Inc Company Overview 128
  • 5.58 University of California Los Angeles Company Overview 129
  • 5.59 University of California San Francisco Company Overview 132
  • 5.60 University of Minnesota Company Overview 133
  • 5.61 University of South Florida Company Overview 134
  • 5.62 University of Wisconsin Madison Company Overview 135
  • 5.63 University of Wolverhampton Company Overview 137
  • 5.64 Valor Medical Inc Company Overview 138
  • 5.65 Vascular Solutions Inc Company Overview 139
  • 5.66 Viket Medical Corporation Company Overview 140
  • 5.67 Weill Cornell Medical College Company Overview 141
  • 5.68 Zoll Medical Corporation Company Overview 142

6 Interventional Neurology- Recent Developments 143

  • 6.1 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors 143
  • 6.2 May 09, 2017: Penumbra Reports First Quarter 2017 Financial Results 143
  • 6.3 May 09, 2017: Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights 144
  • 6.4 May 04, 2017: AxoGen Reports 2017 First Quarter Financial Results 145
  • 6.5 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 146
  • 6.6 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 147
  • 6.7 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 149
  • 6.8 Apr 25, 2017: Stryker reports first quarter 2017 results 150
  • 6.9 Apr 24, 2017: Publication Provides Guidelines to Reduce Transportation Risks Associated with Neurosurgical Laser Ablation Multi-site Workflows 151
  • 6.10 Apr 24, 2017: Medtronic Announces Most Advanced StealthStation for Neurosurgery 152
  • 6.11 Apr 24, 2017: Anaconda Biomed Engages Creganna Medical 153
  • 6.12 Apr 24, 2017: Nexstim Appoints Hanna Kotola as VP of Legal Affairs 153
  • 6.13 Apr 23, 2017: Bard Announces First Quarter Results 153
  • 6.14 Apr 21, 2017: Penumbra Appoints Bridget O'Rourke to its Board of Directors 154
  • 6.15 Apr 19, 2017: ClearPoint Neuro Navigation System's Real-time MRI Guided Platform to be Featured at AANS Practical Clinics for Fourth Consecutive Year 155
  • 6.16 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 155
  • 6.17 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 157
  • 6.18 Apr 11, 2017: Stroke patients in England set to receive revolutionary new treatment 159
  • 6.19 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 160
  • 6.20 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 161
  • 6.21 Apr 04, 2017: $3.6 million to fund personalized 3-D brain maps to guide neurosurgeries 161
  • 6.22 Mar 30, 2017: MPSC Announces 2016 Annual Results 163
  • 6.23 Mar 28, 2017: Nexstim: The decisions of the Board of Directors 164
  • 6.24 Mar 23, 2017: Synaptive Medical Expands Medtech Expertise Through Board Additions 165
  • 6.25 Mar 21, 2017: Metactive Medical Announces Issuance of Patent on Ballstent Embolization Device 166
  • 6.26 Mar 20, 2017: MicroPort NeuroTech Hosts WILLIS Academic Symposium 166
  • 6.27 Mar 15, 2017: Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights 167
  • 6.28 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 170
  • 6.29 Mar 09, 2017: Changes in Nexstim Management Team 170
  • 6.30 Mar 07, 2017: MicroVention And Terumo Announce Data From Multicenter GREAT Study 170
  • 6.31 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 171
  • 6.32 Feb 28, 2017: Nexstim: Financial Statement Release 2016 172
  • 6.33 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 174
  • 6.34 Feb 28, 2017: Penumbra Reports Fourth Quarter and Full Year 2016 Financial Results 177
  • 6.35 Feb 28, 2017: Government of Canada Invests in Research to Advance Patient Care 178
  • 6.36 Feb 23, 2017: New Solitaire Stent Retriever Study Validates Outcomes and Real-World Application of Stroke Treatment Best Practices 179
  • 6.37 Feb 22, 2017: Independent Study Supports Use of Penumbra Aspiration as Frontline Thrombectomy Therapy for Acute Ischemic Stroke 180
  • 6.38 Feb 22, 2017: AxoGen Reports 2016 Fourth Quarter and Full Year Financial Results 181
  • 6.39 Feb 21, 2017: Neuravi Announces Completion of Patient Enrollment in Clinical Trial of a Novel Stent Retriever for Acute Ischemic Stroke 183
  • 6.40 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 184
  • 6.41 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 187
  • 6.42 Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 188
  • 6.43 Feb 14, 2017: MicroPort Receives CFDA Approval for APOLLO Intracranial Stent System in Large Sizes 189
  • 6.44 Feb 09, 2017: Terumo Announces Change of Executive Officers 189
  • 6.45 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 190
  • 6.46 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 191
  • 6.47 Jan 31, 2017: Terumo Opens a Branch in Yangon 193
  • 6.48 Jan 26, 2017: Bard Announces Fourth Quarter Results 193
  • 6.49 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 194
  • 6.50 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 195
  • 6.51 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 198
  • 6.52 Jan 16, 2017: MicroPort Attends 19th Annual Meeting of China Health Economics Association 199
  • 6.53 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 199
  • 6.54 Jan 09, 2017: Anaconda BioMed Appoints Mr. Giovanni Leo to its Advisory Board 201
  • 6.55 Jan 09, 2017: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2016 Revenue 201
  • 6.56 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 202
  • 6.57 Jan 05, 2017: AxoGen Appoints Ivica Ducic Medical Director 203
  • 6.58 Jan 05, 2017: Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors 203
  • 6.59 Jan 04, 2017: MRI Interventions' ClearPoint Surpasses Single-Year Milestone of 500 Procedures in 2016 204
  • 6.60 Jan 03, 2017: Amnis Therapeutics Starts its First Clinical Trial with its Neuro Thrombectomy Device 205
  • 6.61 Jan 03, 2017: Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer 205

7 Appendix 287

  • 7.1 Methodology 287
  • 7.2 About GlobalData 290
  • 7.3 Contact Us 290
  • 7.4 Disclaimer 290

List of Tables

1.1 List of Tables

  • Table 1: Interventional Neurology - Pipeline Products by Stage of Development 17
  • Table 2: Interventional Neurology - Pipeline Products by Segment 18
  • Table 3: Interventional Neurology - Pipeline Products by Territory 19
  • Table 4: Interventional Neurology - Pipeline Products by Regulatory Path 20
  • Table 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 21
  • Table 6: Interventional Neurology - Ongoing Clinical Trials 22
  • Table 7: Interventional Neurology Companies - Pipeline Products by Stage of Development 23
  • Table 8: Interventional Neurology - Pipeline Products by Stage of Development 26
  • Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 10: Alcyone Microcatheter - Product Status 29
  • Table 11: Alcyone Microcatheter - Product Description 29
  • Table 12: Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 13: Golden Retriever - Product Status 30
  • Table 14: Golden Retriever - Product Description 30
  • Table 15: Amnis Therapeutics Ltd - Ongoing Clinical Trials Overview 31
  • Table 16: Golden Retriever - Amnis Therapeutics Thrombectomy Device-First in Man (FIM) Safety and Performance Study 32
  • Table 17: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 18: ANCD BRAIN - Product Status 33
  • Table 19: ANCD BRAIN - Product Description 33
  • Table 20: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 21: Aneurysm Occlusion Saddle - Product Status 34
  • Table 22: Aneurysm Occlusion Saddle - Product Description 34
  • Table 23: Janjua Aneurysm Net - Product Status 35
  • Table 24: Janjua Aneurysm Net - Product Description 35
  • Table 25: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 26: Polymer Stent for Cerebral Aneurysms - Product Status 36
  • Table 27: Polymer Stent for Cerebral Aneurysms - Product Description 36
  • Table 28: Arterain Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 29: Catheter Based System - Product Status 37
  • Table 30: Catheter Based System - Product Description 37
  • Table 31: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 32: Endovascular Embolization Device - Product Status 38
  • Table 33: Endovascular Embolization Device - Product Description 38
  • Table 34: Ischemic Stroke Therapy Device - Product Status 39
  • Table 35: Ischemic Stroke Therapy Device - Product Description 39
  • Table 36: BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 37: GelCoil - Product Status 40
  • Table 38: GelCoil - Product Description 40
  • Table 39: Ceretrieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 40: Device - Ischemic Stroke - Product Status 41
  • Table 41: Device - Ischemic Stroke - Product Description 41
  • Table 42: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 43: Covered Stent - Product Status 42
  • Table 44: Covered Stent - Product Description 42
  • Table 45: Next Generation Balloon Expandable Stent - Product Status 43
  • Table 46: Next Generation Balloon Expandable Stent - Product Description 43
  • Table 47: Next Generation REVIVE SE - Product Status 43
  • Table 48: Next Generation REVIVE SE - Product Description 44
  • Table 49: Self-Expanding Stent - Product Status 44
  • Table 50: Self-Expanding Stent - Product Description 44
  • Table 51: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 52: Collagen-based Coils - Product Status 45
  • Table 53: Collagen-based Coils - Product Description 45
  • Table 54: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 55: Flow Diverter - Product Status 46
  • Table 56: Flow Diverter - Product Description 46
  • Table 57: CranioVation Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 58: Brain Aneurysm Clip - Product Status 47
  • Table 59: Brain Aneurysm Clip - Product Description 47
  • Table 60: CVTec Cerebrovascular Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 61: CoilAlarm - Product Status 48
  • Table 62: CoilAlarm - Product Description 48
  • Table 63: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 64: Aneurysm Clip Applicator - Product Status 49
  • Table 65: Aneurysm Clip Applicator - Product Description 49
  • Table 66: Cerebral Aneurysm Clip - Product Status 50
  • Table 67: Cerebral Aneurysm Clip - Product Description 50
  • Table 68: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 69: Liquid Embolic System - Product Status 51
  • Table 70: Liquid Embolic System - Product Description 51
  • Table 71: Occlusion Balloons - Product Status 52
  • Table 72: Occlusion Balloons - Product Description 52
  • Table 73: EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 74: Ultrasound Catheter Navigation Device - Product Status 53
  • Table 75: Ultrasound Catheter Navigation Device - Product Description 53
  • Table 76: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 77: e-Dura Implant - Product Status 54
  • Table 78: e-Dura Implant - Product Description 54
  • Table 79: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 80: Intracranial Stent - Product Status 55
  • Table 81: Intracranial Stent - Product Description 55
  • Table 82: Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 83: Magellan Robotic System - Neurological Indication - Product Status 56
  • Table 84: Magellan Robotic System - Neurological Indication - Product Description 56
  • Table 85: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 86: Blood Clots Clearing Device - Product Status 57
  • Table 87: Blood Clots Clearing Device - Product Description 57
  • Table 88: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 89: Hybernia Safety Catheter - Neuroprotection - Product Status 58
  • Table 90: Hybernia Safety Catheter - Neuroprotection - Product Description 58
  • Table 91: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 92: SHELTER - Product Status 59
  • Table 93: SHELTER - Product Description 59
  • Table 94: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 95: NVGuard Neurovascular - Product Status 60
  • Table 96: NVGuard Neurovascular - Product Description 60
  • Table 97: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 98: Aspirarecath - Product Status 61
  • Table 99: Aspirarecath - Product Description 62
  • Table 100: Axcelguide - Product Status 62
  • Table 101: Axcelguide - Product Description 62
  • Table 102: Cerulean G - Product Status 63
  • Table 103: Cerulean G - Product Description 63
  • Table 104: Slimguide - Product Status 63
  • Table 105: Slimguide - Product Description 64
  • Table 106: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 107: Artisse Intrasaccular Device - Product Status 65
  • Table 108: Artisse Intrasaccular Device - Product Description 66
  • Table 109: Lazarus Cover - Product Status 66
  • Table 110: Lazarus Cover - Product Description 66
  • Table 111: Lazarus ReCover - Product Status 67
  • Table 112: Lazarus ReCover - Product Description 67
  • Table 113: Medina Embolization Device - Product Status 67
  • Table 114: Medina Embolization Device - Product Description 68
  • Table 115: Pipeline Flex w/Shield - Surface Enhancement - Product Status 68
  • Table 116: Pipeline Flex w/Shield - Surface Enhancement - Product Description 68
  • Table 117: UNO Neurovascular Embolization System - Product Status 69
  • Table 118: UNO Neurovascular Embolization System - Product Description 69
  • Table 119: Medtronic plc - Ongoing Clinical Trials Overview 70
  • Table 120: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study 71
  • Table 121: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 122: Next Generation Device For Cerebral Aneurysm - Product Status 72
  • Table 123: Next Generation Device For Cerebral Aneurysm - Product Description 72
  • Table 124: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 125: Ballstent Microcatheter - Product Status 73
  • Table 126: Ballstent Microcatheter - Product Description 73
  • Table 127: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 128: Clot Retrieval Device - Product Status 74
  • Table 129: Clot Retrieval Device - Product Description 74
  • Table 130: Embolization Coils - Product Status 75
  • Table 131: Embolization Coils - Product Description 75
  • Table 132: Micro-Catheter - Product Status 75
  • Table 133: Micro-Catheter - Product Description 76
  • Table 134: Tubridge - Product Status 76
  • Table 135: Tubridge - Product Description 76
  • Table 136: Vertebral Artery Stent - Product Status 77
  • Table 137: Vertebral Artery Stent - Product Description 77
  • Table 138: MicroPort Scientific Corp - Ongoing Clinical Trials Overview 78
  • Table 139: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms 79
  • Table 140: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 141: Advanced Coil - Product Status 80
  • Table 142: Advanced Coil - Product Description 80
  • Table 143: Advanced WEB Aneurysm Embolization Device - Product Status 81
  • Table 144: Advanced WEB Aneurysm Embolization Device - Product Description 81
  • Table 145: Coated Stent - Product Status 81
  • Table 146: Coated Stent - Product Description 82
  • Table 147: ERIC Retrieval Device - Product Status 82
  • Table 148: ERIC Retrieval Device - Product Description 82
  • Table 149: FRED Flow-Diverting Stent - Product Status 83
  • Table 150: FRED Flow-Diverting Stent - Product Description 83
  • Table 151: WEB Aneurysm Embolization System - Product Status 83
  • Table 152: WEB Aneurysm Embolization System - Product Description 84
  • Table 153: MicroVention, Inc. - Ongoing Clinical Trials Overview 85
  • Table 154: WEB Aneurysm Embolization System - Clinical Assessment of Web Device in Ruptured Aneurysms 86
  • Table 155: WEB Aneurysm Embolization System - CLinical Assessment of WEB Device in Ruptured aneurysms (CLARYS): CLARYS 86
  • Table 156: WEB Aneurysm Embolization System - The WEB Intrasaccular Therapy Study (WEB-IT) 86
  • Table 157: WEB Aneurysm Embolization System - WEB Clinical Assessment of IntraSaccular Aneurysm Therapy 87
  • Table 158: WEB Aneurysm Embolization System - WEB French Observatory 87

List of Figures

1.2 List of Figures

  • Figure 1: Interventional Neurology - Pipeline Products by Stage of Development 17
  • Figure 2: Interventional Neurology - Pipeline Products by Segment 18
  • Figure 3: Interventional Neurology - Pipeline Products by Territory 19
  • Figure 4: Interventional Neurology - Pipeline Products by Regulatory Path 20
  • Figure 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 21
  • Figure 6: Interventional Neurology - Ongoing Clinical Trials 22
Back to Top